Maddox TM,Stanislawski MA,Grunwald GK,Bradley SM,Ho PM,Tsai TT .2014 .Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA, 312 : 1754-63.
Bittencourt MS,Hulten E,Ghoshhajra B,O'Leary D,Christman MP,Montana P .2014 .Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. CircCardiovasc Imaging, 7 : 282-91.
ArteriosclerThrombVascBiol .2015 .. , 35 : 981-99.
Min JK,Dunning A,Lin FY,Achenbach S,Al-Mallah M,Budoff MJ M .2011 .Age and sex related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am CollCardiol, 58 : 849-60.
Lin FY,Shaw LJ,Dunning AM,LaBounty TM,Choi JH,Weinsaft JW .2011 .Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2- center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am CollCardiol, 58 : 510-59.
Hwang IC,Jeon JY,Kim Y,Kim HM,Yoon YE,Lee SP .2008 .Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am CollCardiol, 52 : 1335-43.
.2015 .Association between aspirin therapy and clinical outcomes in patients with non-obstructive coronary artery disease: a cohort study. PLoS One, 10 : e0129584.
Schwalm JR,Purdham D,Kingsbury K . .216 Variation in classification and reporting of coronary anatomy: a provincial survey. , : .
Can J ,S138 Kjekshus J,Apetrei E,Barrios V,Böhm M,Cleland JG,Cornel JH .2007 .Rosuvastatin in older patients with systolic heart failure. N Engl J Med, 357 : 2248-61.
Madelaire C,Gislason G,Kristensen SL,Fosbøl EL,Bjerre J,D'Souza M .2018 .Low-dose aspirin in heart failure not complicated by atrial fibrillation: a nationwide propensity matched study. J Am CollCardiol HF, 6 : 156-67.
Ilyas H,Nawaz H,Zahid M. .2018 .Contrast induced nephropathy in patients undergoing percutaneous coronary intervention. Pak J Med Health Sci, 12(1) : 520-2.
Xue-chao W,Xiang-hua FU,Yan-bo WA,Xin-wei JI,Wei-li WU,Xinshun GU .2011 .Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate. Chinese Med, 124(6) : 892-6.
Larsen P,Shah S,Waxman S,Freilich M,Riskalla N,Piemonte T .2011 .Comparison of procedural times, success rates, and safety between left versus right radial arterial access in primary percutaneous coronary intervention for acute ST‐segment elevation myocardial infarction. Catheter CardiovascInterv, 78(1) : 38-44.
Petroni T,Zaman A,Georges JL,Hammoudi N,Berman E,Segev A,Gheorghiade M.,Sopko G. .2016 .Navigating the crossroads of coronary artery disease and heart failure. Heart, 102(20) : 1648.
Circulation ,2006) M.S. Bittencourt E.,Hulten B.,Ghoshhajra B. .2014 .of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events. CircCardiovasc Imaging, 7 : .